ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Erratum to: C3 glomerulopathy and current dilemmas | JoVE Visualize

Home
Research Domains
Information And Computing Sciences

Erratum to: C3 glomerulopathy and current dilemmas

Naoko Ito¹, Ryuji Ohashi², Michio Nagata³

¹Kidney and Vascular Pathology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.

Clinical and Experimental Nephrology|October 21, 2017

View abstract on PubMed

Summary

This review discusses C3 glomerulopathy, a kidney disease, and highlights current challenges in its diagnosis and treatment. It aims to clarify complex aspects for better patient management.

Area of Science:

Nephrology
Immunology
Pathology

Background:

C3 glomerulopathy is a rare kidney disease characterized by complement system dysregulation.
Distinguishing C3 glomerulopathy from other glomerulonephritis is challenging.
Current diagnostic and therapeutic strategies face several dilemmas.

Purpose of the Study:

To review the current understanding of C3 glomerulopathy.
To discuss the diagnostic dilemmas associated with this condition.
To explore the challenges and potential future directions in managing C3 glomerulopathy.

Main Methods:

Literature review of recent studies on C3 glomerulopathy.
Analysis of diagnostic criteria and classification systems.
Discussion of therapeutic options and their limitations.

Main Results:

C3 glomerulopathy encompasses various histological patterns.
Complement pathway dysregulation is central to its pathogenesis.
Biomarkers and advanced imaging show promise but require validation.

Conclusions:

Accurate diagnosis requires integrated clinicopathological and complement analysis.
Therapeutic strategies are evolving, targeting complement pathways.
Further research is needed to address current dilemmas and improve outcomes.

Other Information And Computing Sciences

Other Information And Computing Sciences Not Elsewhere Classified

Erratum To: C3 Glomerulopathy And Current Dilemmas